✦ LIBER ✦

Predictors of virologic relapse in patients with chronic hepatitis C (CHC) treated with peginterferon alfa-2a (40KD) (pegasys) alone or in combination with ribavirin (copegus)

✍ Scribed by V. Balan; S. Zeuzem; H. Sette; M. Fried; D. Jensen; G. Pastore; P. Marcellin; F. Sedarati

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with chronic hepat

✍ M. Swain; M.-Y. Lai; M.L. Shiffman; W.G. Cooksley; A. Abergel; M. Diago; M. Brun 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Pharmacokinetics of peginterferon ALFA-2

✍ R. Bruno; P. Sacchi; V. Ciappina; E. Maffezzini; S.F.A. Patruno; C. Zocchetti; G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 319 KB

PEG-IFN alfa-2a (40kd) (Pegasys) plus am

✍ G. Ideo; A. Attili; G. Ruggiero; A. Craxi; G. Di Perri; A. Mangia; A. Picciotto; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Predicting sustained virological respons

✍ Peter Ferenci; Michael W. Fried; Mitchell L. Shiffman; Coleman I. Smith; George 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Predicting sustained virological respons

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Pegeinterferon alfa-2a (40 KD) (Pegasys)

✍ P. Marcellin; S. Brillanti; H. Cheinquer; W.G.E. Cooksley; M.L. Shiffman; W.E. S 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 125 KB